Tomomi Hashidate-Yoshida
Overview
Explore the profile of Tomomi Hashidate-Yoshida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lujan A, Foresti O, Wojnacki J, Bigliani G, Brouwers N, Pena M, et al.
J Cell Biol
. 2025 Feb;
224(5).
PMID: 40015245
Loss of TANGO2 in humans precipitates metabolic crises during periods of heightened energy demand, such as fasting, infections, or high fever. TANGO2 has been implicated in various functions, including lipid...
2.
Otsuka Y, Okada M, Hashidate-Yoshida T, Nagata K, Yamada M, Goto M, et al.
Anal Bioanal Chem
. 2024 Nov;
417(2):275-286.
PMID: 39572428
Mass spectrometry imaging (MSI) is a promising analytical method to visualize the distribution of lipids in biological tissues. To clarify the relationship between cellular distribution and lipid types in a...
3.
Kawasaki-Nagano M, Tamagawa-Mineoka R, Kurioka T, Arakawa Y, Nakanishi M, Kishida M, et al.
Exp Dermatol
. 2024 Nov;
33(11):e70015.
PMID: 39513758
Platelet-activating factor (PAF) is an important chemical mediator in the field of inflammation, but its function in the skin is unclear. To unravel the role of PAF, we focused on...
4.
The role of lysophosphatidylcholine acyltransferase 2 in osteoblastic differentiation of C2C12 cells
Tabe S, Hikiji H, Hashidate-Yoshida T, Shindou H, Shimizu T, Tominaga K
FEBS Open Bio
. 2024 Jul;
14(9):1490-1502.
PMID: 39075841
Glycerophospholipids, a primary component of cellular membranes, play important structural and functional roles in cells. In the remodelling pathway (Lands' cycle), the concerted actions of phospholipase As and lysophospholipid acyltransferases...
5.
Tanaka S, Kawakita M, Yasui H, Sudo K, Itoh F, Sasaki M, et al.
Commun Biol
. 2024 Jul;
7(1):782.
PMID: 38951147
Acute immune responses with excess production of cytokines, lipid/chemical mediators, or coagulation factors, often result in lethal damage. In addition, the innate immune system utilizes multiple types of receptors that...
6.
Osawa Y, Kawai H, Nakashima K, Nakaseko Y, Suto D, Yanagida K, et al.
PLoS One
. 2024 May;
19(5):e0303296.
PMID: 38753743
Aim: Metabolic dysfunction-associated steatohepatitis (MASH) is one of the most prevalent liver diseases and is characterized by steatosis and the accumulation of bioactive lipids. This study aims to understand the...
7.
Yamamoto S, Hashidate-Yoshida T, Yoshinari Y, Shimizu T, Shindou H
iScience
. 2024 May;
27(4):109466.
PMID: 38715939
Peripheral nerve injury (PNI) induces debilitating neuropathic pain symptoms, such as tactile allodynia. Accumulating evidence suggests that the expression levels of various transcripts and proteins are drastically changed after PNI....
8.
Murano H, Inoue S, Hashidate-Yoshida T, Shindou H, Shimizu T, Otaki Y, et al.
Am J Respir Cell Mol Biol
. 2024 Feb;
70(6):482-492.
PMID: 38377392
Cigarette smoking is known to be the leading cause of chronic obstructive pulmonary disease (COPD). However, the detailed mechanisms have not been elucidated. PAF (platelet-activating factor), a potent inflammatory mediator,...
9.
Yamamoto S, Hashidate-Yoshida T, Shimizu T, Shindou H
Front Pain Res (Lausanne)
. 2022 Aug;
3:948689.
PMID: 35965594
Peripheral nerve injury (PNI) induces neuronal hyperexcitability, which underlies neuropathic pain. The emergence of RNA sequencing technologies has enabled profiling of transcriptional changes in pathological conditions. However, these approaches do...
10.
Murai H, Kodama T, Maesaka K, Tange S, Motooka D, Suzuki Y, et al.
Hepatology
. 2022 May;
77(1):77-91.
PMID: 35567547
Background And Aims: Immunotherapy has become the standard-of-care treatment for hepatocellular carcinoma (HCC), but its efficacy remains limited. To identify immunotherapy-susceptible HCC, we profiled the molecular abnormalities and tumor immune...